http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017511325-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 2015-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2017511325-A
titleOfInvention Disubstituted 5-fluoropyrimidine derivatives containing sulfonediimine groups
abstract The present invention relates to 5-fluoropyrimidine derivatives containing sulfonediimine groups of general formula (I) as described and defined herein, and methods for their preparation, disorders, in particular hyperproliferative disorders and / or virus-induced infections It relates to their use for the treatment and / or prevention of diseases and / or cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of the compounds of general formula (I).
priorityDate 2014-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9509620-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015537014-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011502956-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018529708-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013037896-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013037894-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466607611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466370766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407367925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466607647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465833244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410983743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467981454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466642417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425507932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91938041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118420966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466424120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468067929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410727567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466643711

Total number of triples: 50.